Review Product Marketing Authorisation For Human Use «Visanne».

Original Language Title: Modifica dell'autorizzazione all'immissione in commercio delmedicinale per uso umano «Visanne».

Read the untranslated law here:

Retrieved February 24, 2015 V&A # 370/2015 determines the authorized the following variation: presentation studio VIPOS (3rd and 4th interim reports) regarding the medicinal product and authorisation authorised pack sizes in Italy following the mutual recognition procedure.
Procedures: NL/H/1569/001/II/016/G.
Types of variation: C.I. 13).
MAh: Bayer S.p.a.
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1 subparagraph 5 of determines AIFA n. 371 of 14/04/2014 published in the Official Journal No. 101 of 03/05/2014.
Date of application of determining this determination is effective on the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica italiana and company will be notified to the holder of the marketing authorisation for the medicinal product.